Clinical trial
Determinants of Efficacy of EsophyX Treatment in Gastro-Esophageal Reflux…
NCT00498082 · Cliniques universitaires Saint-Luc- Université Catholique de Louvain, Other · Unknown status
Key facts
| NCT number | NCT00498082 |
|---|---|
| Title | Determinants of Efficacy of EsophyX Treatment in Gastro-Esophageal Reflux Disease |
| Official title | Determinants of Efficacy of EsophyX Treatment in Gastro-Esophageal Reflux Disease |
| Lead sponsor | Cliniques universitaires Saint-Luc- Université Catholique de Louvain, Other |
| Status | Unknown status |
| Study type | Observational |
| Conditions | Gastroesophageal Reflux Disease |
| Start date | Sep 1, 2007 |
| Completion | Sep 1, 2008 |
| First posted | Jul 9, 2007 |
| Last update posted | Sep 6, 2007 |
| Countries | Belgium |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: